Oh, Jin Kyun
Vargas Del Valle, José G.
Lima de Carvalho, Jose Ronaldo Jr
Sun, Young Joo
Levi, Sarah R.
Ryu, Joseph
Yang, Jing
Nagasaki, Takayuki
Emanuelli, Andres
Rasool, Nailyn
Allikmets, Rando
Sparrow, Janet R.
Izquierdo, Natalio J.
Duncan, Jacque L.
Mahajan, Vinit B.
Tsang, Stephen H.
Funding for this research was provided by:
National Institutes of Health (P30EY019007, R01EY018213, R01EY024698, R01EY026682, R24EY027285, U01EY030580, R01EY028203)
National Cancer Institute (5P30CA013696)
Foundation Fighting Blindness (TA-NMT-0116-0692-COLU, PPA-1218-0751-COLU, Unrestricted funds to the Department of Ophthalmology at the University of California)
Research to Prevent Blindness (Physician-Scientist Award, Unrestricted funds to the Department of Ophthalmology at Columbia University, Unrestricted funds to the Department of Ophthalmology at the University of California San Francisco, Nelson Trust Award for Retinitis Pigmentosa)
National Eye Institute (P30 EY002162)
That Man May See, Inc. (Unrestricted Funds)
Retinitis Pigmentosa Foundation of Puerto Rico
Article History
Received: 24 October 2019
Accepted: 21 March 2022
First Online: 1 April 2022
Declarations
:
: Patient consent was waived as per the Institutional Review Boards at Columbia University (protocol AAAR8743), the University of California, San Francisco (protocol 21-33974), and the University of Puerto Rico (protocol B1960120) due to the retrospective nature of the study design and the minimal risk conferred to patients. All procedures were reviewed and in accordance with the tenets of the Declaration of Helsinki. The data presented in this study was procured through retrospective chart review.
: Not applicable.
: The authors declare that there is no competing interests.